Paper9103224
Studies with IL-10-/- mice: an overview.
Rennick DM and 2 others. J Leukoc Biol, 1997. Cited by 237 papers, by iCite.
Cite this record
ConductScience Library. Studies with IL-10-/- mice: an overview. Papers, record 9103224. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9103224
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-10 | Major topic |
| Animals | |
| Antibody Formation | |
| Enterocolitis | |
| Immunity, Mucosal | |
| Mice |
Source PubMed
Cited by91
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 237 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41555021 | Engineered living glues secrete therapeutic proteins for treatment of inflammatory bowel disease. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/41555021 | PubMed |
| 39683625 | Composition of Human-Associated Gut Microbiota Determines 3-DF and 3-HF Anti-Colitic Activity in IL-10 -/- Mice. | Nutrients | 2024 | https://conductscience.org/library/papers/39683625 | PubMed |
| 36929236 | Interleukin-10 Knockout Mice Do Not Reliably Exhibit Macroscopic Inflammation: A Natural History Endoscopic Surveillance Study. | Dig Dis Sci | 2023 | https://conductscience.org/library/papers/36929236 | PubMed |
| 35401533 | BET Protein Inhibition Regulates Macrophage Chromatin Accessibility and Microbiota-Dependent Colitis. | Front Immunol | 2022 | https://conductscience.org/library/papers/35401533 | PubMed |
| 32326669 | Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models. | Intest Res | 2020 | https://conductscience.org/library/papers/32326669 | PubMed |
| 32240179 | Interleukin-10 contributes to PGE2 signalling through upregulation of EP4 via SHIP1 and STAT3. | PLoS One | 2020 | https://conductscience.org/library/papers/32240179 | PubMed |
| 32159421 | Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task. | Hum Vaccin Immunother | 2020 | https://conductscience.org/library/papers/32159421 | PubMed |
| 31889911 | Exploring the association of IL-10 polymorphisms in Behcet's disease: a systematic review and meta-analysis. | J Inflamm (Lond) | 2019 | https://conductscience.org/library/papers/31889911 | PubMed |
| 31755523 | Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production. | Int Immunol | 2020 | https://conductscience.org/library/papers/31755523 | PubMed |
| 31506328 | Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling. | Gut | 2020 | https://conductscience.org/library/papers/31506328 | PubMed |
| 31304220 | Current concepts in pediatric inflammatory bowel disease; IL10/IL10R colitis as a model disease. | Int J Pediatr Adolesc Med | 2019 | https://conductscience.org/library/papers/31304220 | PubMed |
| 31277323 | Potential Involvement of Salmonella Infection in Autoimmunity. | Pathogens | 2019 | https://conductscience.org/library/papers/31277323 | PubMed |
| 31148944 | The cAMP Pathway Amplifies Early MyD88-Dependent and Type I Interferon-Independent LPS-Induced Interleukin-10 Expression in Mouse Macrophages. | Mediators Inflamm | 2019 | https://conductscience.org/library/papers/31148944 | PubMed |
| 30233512 | A Galacto-Oligosaccharides Preparation Derived From Lactulose Protects Against Colorectal Cancer Development in an Animal Model. | Front Microbiol | 2018 | https://conductscience.org/library/papers/30233512 | PubMed |
| 27980855 | Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. | Eur J Microbiol Immunol (Bp) | 2016 | https://conductscience.org/library/papers/27980855 | PubMed |
| 27562059 | Anti-TNFα alters the natural history of experimental Crohn's disease in rats when begun early, but not late, in disease. | Am J Physiol Gastrointest Liver Physiol | 2016 | https://conductscience.org/library/papers/27562059 | PubMed |
| 27250564 | Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease. | FEBS J | 2016 | https://conductscience.org/library/papers/27250564 | PubMed |
| 27149619 | Influenza Virus Affects Intestinal Microbiota and Secondary Salmonella Infection in the Gut through Type I Interferons. | PLoS Pathog | 2016 | https://conductscience.org/library/papers/27149619 | PubMed |
| 27100390 | Investigation the Possibility of Using Peptides with a Helical Repeating Pattern of Hydro-Phobic and Hydrophilic Residues to Inhibit IL-10. | PLoS One | 2016 | https://conductscience.org/library/papers/27100390 | PubMed |
| 26904722 | Inflammatory Responses to Salmonella Infections Are Serotype-Specific. | Int J Bacteriol | 2013 | https://conductscience.org/library/papers/26904722 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9103224
GET https://conductscience.org/api/papers/v1/9103224/cited_by?page=2